Multiomics sequencing analysis of limb and axial bone metastatic cancer and research on the development of targeted drugs

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500107147

Enrollment

Unknown

Registered

2025-08-05

Start date

2025-09-01

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone metastasis

Interventions

Bone metastasis in limbs:NA

Spinal metastasis:NA

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients whose condition has been confirmed through a comprehensive assessment of medical history, imaging evidence, or pathological sections as being secondary malignant tumors of the bone. 2.Patients who, after assessment through standardized treatment procedures, are clearly identified as requiring surgical treatment.

Exclusion criteria

Exclusion criteria: 1.Patients with multiple primary tumors or with unclear primary tumors. 2.Refusal to voluntarily sign the informed consent form;

Design outcomes

Primary

Measure	Time frame
The composition of cells in the tumor microenvironment,;the composition of metabolites in the tumor tissue;the mRNA expression levels in the tumor tissue;	—

Countries

China

Contacts

Public ContactZeng Hui

Zhejiang Cancer Hospital

zenghui@zjcc.org.cn+86 139 8989 8089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026